Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.
D000293:Adolescent; D000328:Adult; D000588:Amines / Q000378:metabolism; D000818:Animals; D001555:Benzene Derivatives; D001792:Blood Platelets / Q000201:enzymology*; D002247:Carbon Isotopes; D003486:Cyanides / Q000494:pharmacology; D005260:Female; D005664:Furazolidone / Q000494:pharmacology; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007520:Isocarboxazid / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000201:enzymology; D008995:Monoamine Oxidase / Q000097:blood* / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D010949:Plasma / Q000201:enzymology*; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000652:urine
D000588:Amines; D001555:Benzene Derivatives; D002247:Carbon Isotopes; D003486:Cyanides; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D007520:Isocarboxazid; D014191:Tranylcypromine; D005664:Furazolidone; D010293:Pargyline; D007490:Iproniazid; D008995:Monoamine Oxidase; D010624:Phenelzine; D009526:Nialamide; D007538:Isoniazid